You're contacting media contact of this press release

Title: HealthLifeLive Publishes Review of CoreAge Rx Sermorelin Therapy and Its Telehealth-Based Hormone Support Approach

Wichita Falls, TX, United States, 30th Apr 2026 - HealthLifeLive has published a new review article examining Sermorelin therapy offered by CoreAge Rx, highlighting the treatment as a leading option in the hormone-support and anti-aging therapy category. The article explores the science behind Sermorelin, the platform’s physician-guided telehealth process, and the growing demand for remote wellness-focused healthcare solutions.The published review discusses how telehealth platforms are reshaping access to hormone optimization and wellness therapies by allowing patients to complete evaluations, receive physician review, and obtain prescribed medications entirely online. According to the article, HealthLifeLive selected CoreAge Rx’s Sermorelin therapy as a standout option within its category due to its fully digital patient experience, physician oversight, and structured treatment process.Sermorelin is classified as a growth hormone-releasing hormone (GHRH). Rather than introducing synthetic human growth hormone (HGH) directly into the body, Sermorelin works by stimulating the body’s natural hormone production process. The therapy acts on the hypothalamus, which signals the pituitary gland to increase HGH production and subsequently support the release of insulin-like growth factor 1 (IGF-1).The review published on HealthLifeLive explains that this mechanism may support several physiological functions related to metabolism, muscle maintenance, recovery, energy levels, and overall wellness. Because Sermorelin stimulates endogenous HGH production instead of externally replacing it, the article notes that many patients and providers view the therapy as a more physiologically balanced alternative compared to direct HGH therapies.The article also outlines several potential ben...

This press release is issued by King Newswire